Diferencias en el neurodesarrollo infantil temprano tras la infección materna sintomática y asintomática por SARS-CoV-2 durante el embarazo.

Manuela Iglesias, Children's National Health System, Washington, DC, United States; Daniella McCausland, Children's National Health System, Alexandria, VA, United States; Malavika Mahendran, George Washington University School of Medicine and Health Sciences, Washington, DC, United States; Heather Gordish-Dressman, Children's National Health System, Washington, DC, United States; Lora Jackle, Inova Children's Hospital, Falls Church, VA, United States; Jessica Harkness, Inova Children's Hospital, Arlington, VA, United States; Megan Tierney, Inova Fairfax Medical Campus, Alexandria, VA, United States; Renee L. Brenner, Inova Health System, Falls Church, VA, United States; Miranda Newell, Inova Healthcare System, Falls Church, VA, United States; G. Larry Maxwell, Inova Children's Hospital, washington, DC, United States; Robin Baker, Inova Children's Hospital, Washington, DC, United States; Gianluca Ursini, Lieber Institute for Brain Development, Johns Hopkins University, Baltimore, MD, United States; Sarah B. Mulkey, Children's National Health System, Rockville, MD, United States